Technology · Sri Lanka Bureau
US Medical Technology Firm Introduces Robotic Cardiac Surgery to Sri Lanka
SS Innovations International, a US-listed medical technology company, has launched robotic-assisted cardiac surgery capabilities in Sri Lanka, marking a significant advancement in the country's surgical infrastructure. The move is expected to enhance treatment options for heart patients requiring complex procedures.
LSN Sri Lanka ·

SS Innovations International (NASDAQ: SSII), a provider of advanced surgical technology solutions, has announced the introduction of robotic cardiac surgery systems to Sri Lanka's healthcare sector. The development represents an expansion of minimally invasive surgical capabilities in the South Asian nation.
Robotic-assisted cardiac surgery enables surgeons to perform complex heart procedures with greater precision and control than traditional open-heart surgery techniques. The technology typically results in smaller incisions, reduced patient trauma, shorter recovery times, and decreased infection risk—factors that can significantly improve patient outcomes.
The introduction of this technology to Sri Lanka's medical landscape underscores growing efforts to modernize the country's healthcare infrastructure and bring advanced surgical techniques within reach of local patients. Previously, Sri Lankans requiring such specialized procedures often sought treatment abroad at considerable cost.
The initiative aligns with broader regional trends toward adopting cutting-edge medical technologies in South and Southeast Asia. Healthcare facilities in major urban centers across the region have increasingly invested in robotic surgery systems to meet rising demand for advanced cardiac interventions.
SS Innovations International's entry into the Sri Lankan market reflects confidence in the country's healthcare sector and the demand for sophisticated surgical solutions among both private and institutional healthcare providers in the region.